Skip to main content
. 2015 Aug 28;10(8):e0136407. doi: 10.1371/journal.pone.0136407

Fig 4. Patient #2 diagnosed with ER+/PR+/HER2+/Node+ breast carcinoma.

Fig 4

A) Treatments and sample collection indicated in months. B) 48 total somatic mutations were called in the primary breast tumor and/or liver metastasis. 38 mutations were called in the cfDNA using a variant allele percentage cutoff of 1.5%. Genes in red were successfully validated on the Ion Torrent PGM, genes in blue failed to validate, genes were black were not validated.